2024 ISPE Annual Meeting & Expo

Overview

The 2024 ISPE Annual Meeting & Expo is poised to herald a transformative era in pharmaceutical science and manufacturing. The increasing impact of new technology, treatment modalities and digitalization such as artificial intelligence (AI) and machine learning (ML) in the pharmaceutical industry has sparked interest in many areas of development and CMC. More than ever, an emphasis on cross discipline collaboration is needed for these groundbreaking technologies to be implemented and accepted worldwide. This year’s event also seeks to illuminate their profound impact on organizational readiness and the workforce of the future. By fostering global discussions centered on excellence, modernization, and harmonization, we aim to prepare pharma professionals for the challenges and opportunities of an evolving industry landscape.

Our comprehensive education program offers cutting-edge technical sessions, shedding light on the latest advancements in areas like supply chain, operations, facilities, and regulatory affairs, but also emphasizing the role of data science including model-informed drug development (MIDD) and technology in shaping the future of product development, production systems, and quality assurance.

This signature gathering is not just an opportunity to learn but also to connect. From emerging talents to seasoned executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies, attendees will get the chance to network, exchange insights, and preview the latest technologies and services at our expansive Partner Showcase.

Call for Proposals Timeline

Notification will be sent on April 18, 2024.


Content Areas

The importance of a resilient, agile supply chain, as well as strong collaboration between industry and regulators is well recognized. Despite these learnings, an aging population and an unprecedented rise in chronic diseases mean that the need for a constant focus on collaborative innovation and agility will shape Pharma’s priorities in the foreseeable future. ISPE will be the leader to set the pace for knowledge sharing that speaks to both current and future needs of the industry. 

The 2024 ISPE Annual Meeting & Expo Planning Committee is requesting proposals, with preference given to those aligning with the following themes. Submitters are encouraged to also consider identifying related skills and experience for the workforce of the future and strategies for ensuring organizational readiness.

Highlights: ISPE Annual Meeting & Expo through the Years


Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Annual Meeting & Expo.

Name
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Company Type

International Program Committee

Ciby Abraham, PhD
Senior Director and Group Manager, Project and Product Leadership
AstraZeneca
Chair
David Churchward
Head of Operations Quality, Compliance and External Affairs
AstraZeneca
Executive Chair
Lisa J. Graham, PhD, PE
Chief Executive Officer
Seeq Corporation
Past Chair
Michael L. Rutherford
Retired, Computer Systems Quality & Data Integrity
Board Liaison
John Noble
Vice-President and General Manager, Life Sciences
Jacobs
Foundation Liaison
Hugo Hamel, MSc, MBA
Manager, Biotherapeutic Quality Division
Health Canada
Advisor to the Global Regulatory Town Hall
Niranjan S. Kulkarni, PhD
Senior Director, Consulting Services
CRB
Connie Langer
Senior Director, Quality Operations/Environmental Health & Safety
Pfizer
Shanshan Liu
Director
No Deviation Pte Ltd
Peter G. Millili, PhD
Senior Director, Manufacturing Science and Technology
Johnson & Johnson
Robert E. Perks, MSc, CEng
Senior Director, Business Development
PQE US Inc.
Charlie C. Wakeham
Director
WakeUp To Quality
Aaron Weinstein
Senior Director, Compliance Consulting
IPS – Integrated Project Services, LLC
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH
Chelsea Coffey, MSc, MBA, PMP
Manager, Clinical Supply Chain Operations
Biomarin
Emerging Leader
Amanat Kaur
Operational Excellence Engineer
Thermo Fisher Scientific
Emerging Leader
Ryan Paul Mazur
Process Engineer II
Genesis AEC
Emerging Leader
Mark O'Connor
Operations Lead and Start-up Manager
AstraZeneca
Emerging Leader
Silas Tamufor
Quality Assurance, R&D Clinical Injectable Manufacturing
Sanofi
Emerging Leader